Injectable GHK-Cu bypasses absorption barriers entirely, delivering therapeutic concentrations directly into your system
Absence of clinical safety data No Phase 1 clinical safety trial for BPC-157 has been completed and published
It is not approved by the FDA, EMA, or any regulatory authority for human therapeutic use, diagnosis, treatment, or supplementation
Dramatic gastric emptying delay: Most powerful effect of amylin Slows stomach emptying significantly Food stays in stomach 2-3x longer Extended fullness sensation Reduced appetite through mechanical fullness Limits food intake naturally 2
Clinical trials show that 5 grams of specific collagen peptides daily can significantly increase bone mineral density at the lumbar spine and femoral neck in postmenopausal women
It has been investigated as part of studies on aging biology and genome stability